Safety and Immunogenicity Among Adults of Fluzone Quadrivalent, Fluzone Intradermal, and Fluzone High-Dose Influenza Virus Vaccines, 2013-2014 Formulations
Phase of Trial: Phase IV
Latest Information Update: 07 Oct 2014
Price : $35 *
At a glance
- Drugs Influenza virus vaccine (Primary) ; Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- Sponsors sanofi pasteur
- 17 Sep 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 25 Sep 2013 Planned End Date changed from 1 Oct 2013 to 1 Aug 2014 as reported by ClinicalTrials.gov.
- 25 Sep 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.